Krane Funds Advisors LLC Bristol Myers Squibb CO Transaction History

Krane Funds Advisors LLC

$3.44 Billion
Q3 2025

A detailed history of Krane Funds Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Krane Funds Advisors LLC holds 9,053 shares of BMY stock, worth $423,770. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,053

Previous 9,449 4.19%

Holding current value

$423,770

Previous $437,000 6.64%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$43.31 - $48.98 $17,150 - $19,396	-396 Reduced 4.19%	9,053 $408,000
Q2 2025 Aug 11, 2025	BUY	$44.12 - $59.6 $59,959 - $80,996	1,359 Added 16.8%	9,449 $437,000
Q1 2025 Apr 28, 2025	SELL	$53.9 - $63.11 $53,792 - $62,983	-998 Reduced 10.98%	8,090 $493,000
Q4 2024 Feb 13, 2025	SELL	$51.92 - $59.94 $86,446 - $99,800	-1,665 Reduced 15.48%	9,088 $514,000
Q3 2024 Oct 21, 2024	BUY	$39.66 - $51.75 $404,413 - $527,694	10,197 Added 1833.99%	10,753 $556,000

Q3 2024 Oct 16, 2024	SELL	$39.66 - $51.75 $371,534 - $484,794	-9,368 Reduced 94.4%	556 $28,000
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $20,205 - $26,600	-502 Reduced 4.81%	9,924 $412,000
Q1 2024 Apr 16, 2024	BUY	$47.98 - $54.4 $241,723 - $274,067	5,038 Added 93.5%	10,426 $565,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $209,918 - $250,490	-4,330 Reduced 44.56%	5,388 $276,000
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $46,022 - $51,460	795 Added 8.91%	9,718 $564,000
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $14,525 - $16,128	228 Added 2.62%	8,923 $571,000
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $12,024 - $13,638	-183 Reduced 2.06%	8,695 $609,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $101,966 - $120,743	-1,489 Reduced 14.36%	8,878 $639,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $14 - $8,452	-110 Reduced 1.05%	10,367 $737,000
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $225,993 - $248,897	-3,112 Reduced 22.9%	10,477 $807,000
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $439,151 - $526,581	7,143 Added 110.81%	13,589 $992,000
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $43,654 - $50,891	-814 Reduced 11.21%	6,446 $402,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $617,498 - $723,319	-10,436 Reduced 58.97%	7,260 $430,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $724,408 - $788,881	11,701 Added 195.18%	17,696 $1.18 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $271,421 - $305,268	-4,574 Reduced 43.28%	5,995 $378,000
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $235,579 - $266,954	4,080 Added 62.88%	10,569 $656,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $9,073 - $10,055	-158 Reduced 2.38%	6,489 $391,000
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $80,695 - $94,340	-1,472 Reduced 18.13%	6,647 $391,000
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $35,403 - $51,449	-763 Reduced 8.59%	8,119 $453,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $437,083 - $570,135	8,882 New	8,882 $570,000

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krane Funds Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krane Funds Advisors LLC with notifications on news.

Account

Krane Funds Advisors LLC Bristol Myers Squibb CO Transaction History